Urinary bladder malformations associated with bladder outlet obstruction are a frequent cause of progressive renal failure in children. We here describe a muscarinic acetylcholine receptor M3 (CHRM3) (1q41-q44) homozygous frameshift mutation in familial congenital bladder malformation associated with a prune-belly-like syndrome, defining an isolated gene defect underlying this sometimes devastating disease. CHRM3 encodes the M3 muscarinic acetylcholine receptor, which we show is present in developing renal epithelia and bladder muscle. These observations may imply that M3 has a role beyond its known contribution to detrusor contractions. This Mendelian disease caused by a muscarinic acetylcholine receptor mutation strikingly phenocopies Chrm3 null mutant mice.
Lower urinary tract and/or kidney malformations account for 40% of childhood end-stage renal failure. 1 Advances have been made in unraveling the genetic pathogenesis of kidney anomalies, 2 but less is known about the genetic origin of malformations of the lower tract. Congenital bladder outflow obstruction (BOO) has several causes, the commonest being posterior urethral valves (PUVs), with a high risk of developing chronic renal insufficiency. 1, 3 Recently, mutations of HPSE2 (MIM 613469; see Web Resources), encoding a heparanase inhibitor expressed in developing urinary tracts, were described in urofacial syndrome (UFS [MIM 236730]), which presents with a dysmorphic, poorly emptying bladder. 4 Also associated with congenital bladder dysfunction is prune belly syndrome (PBS [MIM 100100]). In its rare complete form, it comprises megacystis with disorganized detrusor muscle, cryptorchidism and thin abdominal musculature with overlying lax skin. PUV and PBS generally occur sporadically, although families have been reported with more than one affected member. 3, 5, 6 We here describe a homozygous loss-of-function mutation of muscarinic acetylcholine receptor M3 (CHRM3) (1q41-q44) in five brothers with a PBS-like syndrome (Figures 1 and 2 ). CHRM3 (MIM 118494) encodes the M3 subtype of muscarinic acetylcholine (ACh) receptors, the major receptor mediating urinary bladder contraction upon micturition. 7 We restudied a family reported in 2005 5 when there were four surviving boys with congenital BOO born to consanguineous Turkish parents. A fifth affected male sibling had died soon after birth as a result of renal failure and urosepsis (II-1). He and one affected surviving brother (II-4) displayed marked abdominal wall distension and were assigned as having PBS, whereas their three brothers were considered to have ''PUV'' because cystopscopy noted urethral valve-like structures. Recently, a sixth brother (II-7) was born, also with a malformed bladder. Evaluation of available cystograms showed massive and irregular-walled bladders with diverticulae ( Figure 1 ). Vesicoureteric reflux was a variable feature. Urethral patency appeared normal in available cystograms. Cystometry performed in four affected boys in the first years of life revealed detrusor hyporeflexia with high residual volumes after micturition. Thus, the collective features in this kindred are most consistent with the PBS spectrum. Affected individuals also had bilaterally impaired pupillary constriction to light ( Figure 1 ) and dry mouths. These examinations were performed after informed consent was obtained from the patients and their parents. Ethical approval for this study was obtained from the ethics review board at the Ruprecht-Karls-University Heidelberg and the collaborating institutions, according to the Declaration of Helsinki.
Using a SNP chip-based genome-wide linkage approach, we previously identified two regions of homozygosity on chromosomes 1 (35 cM) and 11 (9 cM) in four affected surviving males of this family ( Figure 2) . 5 Exon capture and massively parallel sequencing now lead to the identification of the causative genetic defect in CHRM3, located in the chromosome 1 critical interval ( Figure 2 transmembrane domains and the major receptor involved in mediating urinary bladder contraction upon micturition. 7 Both the obvious loss-of-function nature of the CHRM3 mutation and the striking similarity of the human phenotype to Chrm3 null mutant mice (discussed below) underscored the likelihood of this mutation being the causal genetic lesion in our family. The p.Pro392Alafs*43 mutation induces a premature termination codon (PTC) at position 435. If mutant RNA transcripts were stable and translated, a truncated M3 protein would be generated lacking part of the third cytosolic loop, transmembrane domains VI and VII and the C terminus of the receptor. Three-dimensional structure predictions of mutant M3 suggest perturbed folding of the remaining third intracellular loop (Figure 2 ), known to be essential for signal transduction through G protein activation and scaffold protein interaction. 12 Sanger sequencing was performed for individuals II-2, II-3, II-4, II-5, II-6, II-7, I-1, and I-2 of the family. The c.1173_1184 delinsT; p.Pro392Alafs*43 mutation of CHRM3 cosegregated consistently with the disease phenotype according to a recessive mode of inheritance 5 and was absent from 374 Turkish control chromosomes -v2 using Protein Data Bank (PDB) entries 2rh1, 2rh1A and 1r5sA as template. 31 Structures were processed with Jmol. Model reliability is R75% for wild-type and mutant (excluding the mutant C terminus) and 55%-75% for the mutant C terminus.
( To date, human mutations of nicotinic acetylcholine receptor subunits have been described, e.g., in the fetal akinesia deformation sequence (MIM 208150) where they seem to be involved in morphogenetic signal transduction in addition to skeletal muscle contraction. 15 Our report describes a Mendelian human disease caused by a muscarinic acetylcholine receptor mutation, linking a developmental disorder of the renal tract to a component of the parasympathetic nervous system. Key functions of the bladder are to act as a low-pressure reservoir for urine and to expel urine per urethra. The latter is driven by detrusor contractions stimulated by parasympathetic nerves. Although male and female adult human bladders express mRNA of two muscarinic acetylcholine receptor subtypes (M2 and M3), 16, 17 only M3 is the critical receptor for micturition, 7 mediating 95% of cholinergic contraction of the detrusor muscle. 18 In mice and rats, M3 is observed in bladders of both young animals and adults. 19, 20 For determining the localization of M3 in embryonic and fetal tissue, immunohistochemistry studies were performed with M3 antibodies in wild-type mice and human embryos (Figure 3) . 21 The latter were collected with informed consent under Polkinghorne Committee guidelines and staged by the Carnegie classification or foot length. In embryonic day 13 mice, M3 was present in nascent bladder and urethral epithelia. Later in mouse gestation, when the bladder becomes muscularized, M3 was immunodetected in bladder urothelial and detrusor muscle layers. M3 was also localized in ureteric and metanephric kidney nephron precursors. In normal human embryos, M3 protein was detected in urogenital sinus and urethral epithelia and in the late first trimester bladder in urothelia and muscle cells. M3 protein is therefore not only present in fetal bladder muscle but also in the urogenital sinus and fetal urethral epithelia, concurring with sites of embryonic Chrm3 mRNA expression according to Mouse Genome Informatics and GUDMAP databases (see Web Resources). GUDMAP also reports Chrm3 transcripts in the metanephros, and we detected M3 protein in nephron precursors. Collectively, these observations may imply that M3 has a role beyond its known contribution to detrusor contractions. Preliminary GUDMAP data exists that ChAT transcripts are expressed in embryonic kidneys as well as in embryonic bladder and urethral mesenchyme. If the encoded protein, choline acetyltransferase (ACh), is also detectable, non-neuronal ACh may be synthesized in the nascent renal tract. In future studies, it will be interesting to address the possibility that ACh is also expressed in non-neuronal tissues.
In homozygous Chrm3 mutant mice lacking M3, adult detrusor contractility to carbachol ex vivo is impaired and (only) male mutant adult bladders are grossly distended in vivo. 18 Although it is unknown whether megacystis is present in younger Chrm3 mutant mice, the hypocontractile bladder phenotype is very similar to humans with CHRM3 mutations, described above. Of note, only male Chrm3 mice will develop clinical disease. This is, at least in mice most probably, related to differences between male and female urethral anatomy with male bladders being more contractile to force the urine through the longer urethra. Alternatively, female mice (but not males) might have other compensatory physiological mechanisms allowing them to empty their bladders independent of M3 action. Expression and function of M3 in rat and guinea pig urinary bladders do not seem to differ considerably between male and female animals 22 and with regard to overall muscarinic responsiveness this situation appears to be similar in humans. 23 In humans, we can neither rule out nor confirm a male-limited phenotype: the pedigree of the presented index family is not helpful to delineate the phenotype of female homozygous CHRM3 mutation carriers given that no female individual is affected by such a mutation. Mother and sister of the index person are both heterozygous mutation carriers with apparently normal bladder anatomy and function. With respect to PBS, the full clinical picture, including BOO, cryptorchidism, and abdominal wall distension, is limited to males; however, incomplete forms of PBS have also been described in females. 24, 25 The etiology of abdominal muscle deficiency in individuals with PBS has been a matter of controversy. Either a common underlying defect of mesodermal development is proposed 25 or, as other authors suggest, abdominal muscle deficiency seems to be a nonspecific anatomic defect that is secondary to fetal abdominal wall distention (caused by megacystis, hydronephrosis or constipation). 26 In the present study, RT-PCR experiments were performed on RNA extracted from human mature abdominal wall musculature, but no M3 expression was apparent ( Figure S1 ). These data are in favor of abdominal wall distension being a secondary event after megacystis and/ or urinary stasis due to impaired urinary bladder contraction early in fetal life. Failure of bladder contractility before birth in humans with homozygous (or compound heterozygous) CHRM3 mutation might contribute to the observed bladder dysmorphology postpartum. Bladder dysfunction is likely to persist in individuals with CHRM3 mutation thoughout life, constituting an important risk factor for the progression of renal insufficiency.
3 Chrm3 mutant mice also display impaired salivation and dilated pupils, consistent with a role for muscarinic ACh actions in serous salivary secretion and pupillary constriction, 18 and a similar phenotype is present when human CHRM3 is mutated. will witness the unraveling of genetic causes of bladder malformations, thus providing insights into the mechanisms of both normal development and explaining how bladder dysmorphology arises in the context of PBS, PUV, UFS and other related syndromes. 3 
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